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Guanidine administration may be beneficial in the treatment of amyotrophic 
lateral sclerosis and related diseases; however, the actions of guanidine on the 
mammalian central nervous system have not been investigated. We studied the 
effects of this compound on neuronal properties and synaptic transmission in 
isolated slices of guinea pig olfactory cortex using intra- and extracellular recording 
methods. Addition of guanidine to the superfusate (3300 pM) produced the 
following effects. (a) Excitatory and inhibitory postsynaptic potentials, evoked by 
stimulation of the lateral olfactory tract, were increased in amplitude and duration; 
(b) the amplitude and frequency of spontaneously occurring postsynaptic potentials 
was significantly increased; (c) membrane potential and input resistance remained 
virtually unchanged; and (d) the duration of the lateral olfactory tract compound 
action potential was prolonged. These results suggest that guanidine enhances the 
release of excitatory and inhibitory neurotransmitters in the mammalian cortex and 
this effect may be beneficial in human central nervous system diseases in which the 
efficiency of synaptic transmission is reduced. 
INTRODUCTION 
Effects of guanidine on the peripheral and central nervous system were 
first described more than 100 years ago (7). Since then, the actions of 
guanidine on transmission at the neuromuscularjunction of frogs (5, 16,18, 
22), mammals (9, 15,30), and even humans (10, 11) have been investigated 
in detail. Those studies revealed that guanidine facilitated the release of 
neurotransmitter from presynaptic terminals and this action was shown to 
Abbreviations: LOT--lateral olfactory tract; EPSP, IPSP-excitatory, inhibitory post- 
synaptic potential; TTX-tetrodotoxin. 
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be of use in the treatment of some human disorders of neuromuscular 
transmission, such as botulism (3,24) and the myasthenic syndrome (14,21). 
The description of facilitatory actions on neuromuscular transmission 
led to the trial of guanidine as a treatment for patients suffering from 
degenerative diseases of the central nervous system (20). Although these 
trials are still preliminary (31), there is some evidence to suggest that 
guanidine treatment can slow the progress of diseases such as amyotrophic 
lateral sclerosis (17, 20) and spinal muscular atrophy (29). However, the 
mechanism of action of guanidine on the central nervous system has been 
only partially investigated. Administration of the drug was reported to have 
the following effects: (a) an augmentation of spontaneous and stimulus- 
induced potentials in ventral and dorsal roots of the cat spinal cord (13); (b) 
an increased amplitude and frequency of spontaneous postsynaptic 
potentials, and an enhancement of stimulus-induced postsynaptic poten- 
tials recorded from motoneurons in the frog spinal cord (8); and (c) an 
increase in the excitability of single axons in the lamprey spinal cord (18). 
The present experiments were undertaken to obtain more information 
about the effects of guanidine on the mammalian central nervous system, 
and perhaps to provide some explanation for its beneficial effects in 
degenerative nervous diseases. We studied the actions of guanidine on 
synaptic transmission in the guinea pig isolated olfactory cortex and on 
conduction along the isolated lateral olfactory tract. A preliminary report 
of these results has been presented (6). 
METHODS 
Guinea pigs of either sex weighing 300 to 400 g were decapitated and 
surface slices of olfactory cortex approximately 0.5 mm thick were cut by 
hand using a razor blade and recessed Perspex guide (26). Slices were 
maintained at 25°C in Krebs’s solution of the following composition (mM): 
NaCl, 118; KCl, 1.8; NaHCO,, 25; KHzPOI, 1.2; MgS04, 1.2; CaCl,, 2.5; 
D-ghCOSe, Il. In all experiments drugs were added in fixed concentrations 
to the incubation medium and all solutions were equilibrated with 95% 
02-5% CO,. For intracellular recording, slices were placed in a small bath 
and superfused at a rate of about 5 mYmin. Recordings were obtained from 
neurons in the prepyriform or periamygdaloid regions using a single 
microelectrode (80 to 120 MR) filled with 4 M potassium acetate buffered to 
pH 7.4 with acetic acid (26). Neurons were orthodromically stimulated (20 
to 40 V, 0.3 ms) via a pair of platinum electrodes placed across the cut end 
of the lateral olfactory tract. Only cells with initial resting membrane 
potentials of ~50 mV were selected and potentials were displayed on an 
oscilloscope and chart recorder. In addition, data were stored on magnetic 
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tape for subsequent analysis. A Nicolet Med 80 computer was used to 
count spontaneously occurring postsynaptic potentials. 
Extracellular field potentials were recorded using Ag/AgCl electrodes 
and differential recording as described by Brown and Galvan (2). 
In a number of experiments, slices approximately 0.3 mm thick were cut 
and the lateral olfactory tract was then dissected free of the surrounding 
cortex. The central end was drawn into a suction electrode and the 
peripheral end was stimulated intermittently with rectangular pulses (0.1 
ms, submaximal voltage). The nerve fiber population action potential 
recorded from the suction electrode was displayed on an oscilloscope (AC 
coupled) and potentials were averaged using a signal averager (Didac 400). 
The drug sources were guanidine hydrochloride, Merck; tetrodotoxin, 
Calbiochem. 
RESULTS 
Intrucellular Recording 
Intracellular recordings were obtained from 16 neurons in 12 slices and 
guanidine was applied to the bathing solution in concentrations of 500 pM to 
5 mM. In the guanidine solution, synaptically evoked potentials were 
clearly prolonged in duration and either increased or decreased in 
amplitude. In addition, there was a marked increase in the amplitude and 
frequency of spontaneously occurring, postsynaptic potentials. Changes in 
membrane potential and apparent input resistance were small and 
sometimes absent. The effects of guanidine were slow in onset and 
therefore the drug was applied for 10 to 60 min. 
Stimulus-Induced Postsynaptic Potentials. Figure 1 shows examples of 
lateral olfactory tract evoked postsynaptic potentials recorded before and 
during application of guanidine. Orthodromic activation of olfactory cortex 
neurons by stimulation of the lateral olfactory tract (LOT) normally 
produced the following sequence of postsynaptic potentials (Fig. IA): an 
excitatory postsynaptic potential (EPSP, duration about 30 ms) with a 
single action potential. This was followed by a slowly decaying (about 150 
ms) depolarizing potential, which had the properties of an inhibitory 
postsynaptic potential [IPSP, (27)]. In the control solution, the complete 
orthodromic response lasted about 200 ms, but in guanidine solution this 
was increased to between 500 and 1000 ms (eight neurons tested, see Figs. 
lA-D). 
Simple prolongation of LOT-evoked potentials was not the only effect of 
guanidine. Some cells exhibited “afterdischarges” an example of which is 
shown in Fig. 1F. Such afterdischarges or rhythmic oscillations of the 
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FIG. 1. Effects of guanidine on orthodromically evoked postsynaptic potentials (PSP) 
recorded from neurons in the olfactory cortex. A, C, and E are controls taken from three 
different experiments. B (stimulation frequency 0.025 Hz) shows one lateral olfactory 
tract-evoked PSP after 60 min in 500 pM guanidine; note the decreased excitatory 
postsynaptic potential amplitude, double spike, and the prolonged duration. In D (0.017 Hz), 
recorded after 10 min in 2 mM guanidine, the EPSP amplitude was clearly increased. F (0.025 
Hz) illustrates an example of spontaneous afterdischarges after a single lateral olfactory tract 
stimulus (arrow) recorded after 37 min in 2 mM guanidine solution. Dashed line in all records 
indicates projected baseline: spikes retouched in E and F. 
membrane potential after a single LOT stimulus were typical effects of 
higher concentrations of guanidine (32 mM). 
We also observed changes in the amplitude of the LOT-evoked 
potentials; in two cells guanidine clearly increased the amplitude of the 
EPSP (Fig. ID), whereas in the other six cells there was either a decrease 
(Fig. IB) or no effect. 
Spontaneous Postsynaptic Potentials. Figure 2 illustrates spontaneous 
postsynaptic potentials and LOT-evoked synaptic potentials before and 
during exposure to 2 mM guanidine. In the control solution, spontaneous 
depolarizing postsynaptic potentials a few millivolts in amplitude could be 
observed. Addition of guanidine increased the amplitude and frequency of 
spontaneously occurring potentials in this and 10 other neurons of the 16 
tested. Figure 2 also illustrates that the increase in spontaneous 
postsynaptic activity was accompanied by a prolongation of the 
LOT-evoked postsynaptic potential. When tetrodotoxin (TTX, lo-’ g/ml) 
238 GALVAN, GRAFE. AND TEN BRUGGENCATE 
Guanidine 2mM 
c 
FIG. 2. Effect of 2 mM guanidine on orthodromic transmission and spontaneous 
postsynaptic potentials. In each panel the top line shows the response to a single orthodromic 
stimulus (30 V, 0.3 ms, 0.017 Hz) and the lower lines are high-amplification oscilloscope 
records of the membrane potential. The numbers above each panel show the time (min) after 
adding guanidine; tetrodotoxin (TTX) was added to the medium 9 min after guanidine. Note 
that in the control there are several low-amplitude spontaneous potentials, the amplitude and 
frequency of which were greatly enhanced by guanidine. Additionally, the duration of the 
orthodromic responses was significantly prolonged (dashed line indicates projected baseline) 
and the amplitude of the excitatory postsynaptic potential was increased (horizontal arrow 
indicates control amplitude). TTX abolished all spontaneous activity and blocked the action 
potential. Time calibration: 400 ms for spontaneous activity; 100 ms for orthodromic 
responses. 
was added to the superfusate, all spontaneous potentials were abolished 
within a few minutes and the orthodromic action potential was blocked. 
The effect of guanidine on spontaneous potentials was not immediate in 
onset and was both time- and concentration-dependent. Figure 3 
specifically illustrates this point and shows that low concentrations (about 1 
mM) required longer application times to induce modest increases in 
spontaneous activity whereas higher concentrations (2 to 5 mM) usually 
produced massive increases in activity after only a few minutes. When an 
increase in spontaneous activity has been induced, it persisted for many 
minutes despite removing guanidine from the superfusate (Fig. 3). 
Spontaneous potentials had a duration of about 50 ms and although they 
sometimes reached an amplitude of 10 mV or more, they did not usually 
elicit action potentials. 
Guanidine-induced spontaneous activity could be rapidly abolished by 
addition of either 15 mM MgClz (three cells tested; Fig. 5) or tetrodotoxin 
lo+ g/ml (four cells tested; Fig. 2). 
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FIG. 3. Computer plot of the effect of (A) 1 and (B) 2 mM guanidine on the frequency of 
spontaneously occurring postsynaptic potentials. Ordinates show the number of spontaneous 
potentials per minute; abscissae show the time from the start ofrecording. The vertical arrows 
indicate the duration of drug application. A and B were recorded from different cells in 
different slices. 
Membrane Potential and Resistance. The effects of guanidine (500 PM to 
! mrvr) on membrane potential and neuron apparent input resistance are 
ummarized in Table I. No clear changes in the membrane potential were 
observed during the first few minutes of guanidine application and 
esistance changes were small and inconsistent. Figure 4 shows the 
:urrent-voltage relationship of one cell before, and 40 min after the 
.pplication of 2 mM guanidine. During this time, the cell depolarized 1 mV 
nd its resistance was only slightly increased. 
Sometimes it was noted that during long drug applications, there were 
mall depolarizations and decreases in resistance (Fig. 5). These effects 
ccurred at approximately the same time as the spontaneous activity was 
eginning to increase and could be reversed by application of MgCl, or 
:trodotoxin. This suggests that they were secondary to the increase in 
pontaneous transmitter release. 
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TABLE 1 
Effect of Guanidine on Membrane Potential and Apparent Membrane Resistance 
Concentration 
(mW Cetl” 
E,” AEMC &lb AR,” 
(mv) (mV) (MN (Mfl) 
0.5 1 -75 +3 4.5 -5 
0.5 2 -77 0 *d * 
1 4 -40 -I 17 c2 
1 2 -77 +2 * * 
1 5 -51 +1 * * 
2 1 -72 +2 40 c3 
2 8 -80 +5 * * 
2 9 -68 0 16 4-7 
a Data analysis has been restricted to the six cells whose membrane potential was stable 
enough to allow accurate estimation of the resting membrane potential. 
@E,,, = resting membrane potential; R, = resting membrane resistance (calculated from 
the amplitude of electrotonic potentials produced by constant-cu~ent pulses). 
c AE, and AR, = changes in membrane potential and resistance respectively; measured 
between 5 and IS min after application of guanidine. 
d Not measured. 
Extracellular Recording 
Field Potentials. Stimulation of the LOT produced a characteristic 
surface-negative field potential lasting about 25 ms. As described 
previously (23,32) this field potential (N-wave) is thought to represent the 
population EPSP generated in the superficial dendrites of the pyramidal 
neurons. 
Addition of guanidine to the superfusate altered the amplitude and 
duration of the field potential in a concentration-dependent manner (10 
preparations tested). After at least a lo-min application, 300 PM guanidine 
increased the amplitude of the N-wave by 14 2 5% (mean -e SD; N = 4); 
500 FM (Fig. 6A) increased the amplitude by 28 -t 7% (IV = 3). Both 
concentrations also induced a late surface negative potential (Fig. 6A). This 
effect was reversible by washing for about 20 min. A 60-min application of 
100 PM guanidine was without effect (three experiments). Higher 
concentrations (3 1 mM) had more complex effects. After a few minutes 
sup~~usion, we observed a clear increase in N-wave ampIitude (Fig. 6B) 
associated with the appearance of a large, long-duration, late surface- 
negative potential (* 1 s). Continued application of guanidine then resulted 
in a reduction in N-wave amplitude, whereas the duration of the late 
potential continued to increase (Fig. 6B). In addition we sometimes 
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FIG. 4. Current-voltage relationships measured before (0) and 40min after (0) addition of 
2 mMguanidine. During this time, the cell depolarized by 1 mV and the resistance rose slightly. 
The insets (bottom right) show examples of electronic potentiak produced by injecting current 
through the microelectrode: C-control. G-during guanidine. Resting potential was -72 mV. 
observed rhythmic DC oscillations following a single LOT stimulus, which 
strongly resembled those observed intracellularly. The effects of high 
concentrations of guanidine were slowly reversible by washing for several 
hours. 
Lateral 0~~~~~~ Tracr. Recordings from the isolated lateral olfactory 
tract revealed that 500 PM guanidine prolonged the duration of the fiber 
copulation action potential by 19 -+ 6% (N = 5) with little‘or no change in 
amplitude (Fig. 60. Higher concentrations caused a more marked 
>rolongation with some decrease in amplitude. These effects were slow in 
Inset (5 to 15 min) and were slowly reversible by washing. MgCI, (15 mM) 
fid not reverse the action of guanidine on the LOT: however. tetrodotoxin 
:ompletely abolished conduction. 
DISCUSSION 
The results suggest that guanidine can facilitate spontaneous and 
timulus-induced release of neurotransmitter substances in the guinea pig 
iolated olfactory cortex. This conclusion is in general agreement with the 
es&bed actions of guanidine on central and peripheral synaptic 
-ansmission in higher and lower vertebrates. 
The spontaneo~ls postsynaptic potentiaIs which we observed during 
uanidine application appear similar to miniature end-plate potentials and 
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FIG. 5. Effect of guanidine (1 mM) on the membrane potential of an olfactory cortex neuron 
recorded (A) at low amplification and slow speed on a potentiometric recorder and (B) at high 
amplification and fast speed on an oscilloscope. The downward deflections in A are the 
membrane responses to negative intracellular current pulses (300 ms, 0.5 nA, 0.025 Hz); the 
higher frequency of current pulses (at +40 min and +53 min) was used to adjust bridge 
balance. Guanidine application was started at the point indicated by the open arrow and the 
horizontal bar indicates the duration of MgC& superfusion. The oscilloscope records in B 
were taken before, 28, 44, and 51 min after the start of guanidine application and the solid 
arrows indicate these times in the recording in A. Guanidine did not immediately alter the 
resting potential (indicated by the dashed line), but after some time there was a depolarization 
of about 5 mV and an increase in the amplitude and frequency of spontaneously occurring 
postsynaptic potentials. Both these effects were reversed by 15 mM MgCl,. 
miniature postsynaptic potentials recorded from frog motoneurons (4, 12). 
These are both characterized by the fact that their frequency and amplitude 
are relatively unaffected by MgClz and TTX (4, 12). In our experiments, 
both these compounds abolished guanidine-induced spontaneous poten- 
tials suggesting that these are not generated by the mechanism responsible 
for the occurrence of miniature potentials. This confirms the findings of 
Grafe and Sonnhof (8), who showed that in high-Mg2+ solution, guanidine 
did not alter the frequency and amplitude of spontaneously occurring 
postsynaptic potentials in frog motoneurons. 
Matthews and Wickelgren (18) suggested that the occurrence of 
guanidine-induced spontaneous potentials results from an increased 
excitability in axons and/or nerve terminals leading to spontaneous action 
potentials. This theory could explain the occurrence of “giant potentials” 
at the frog neuromuscular junction (18, 22) and is also consistent with our 
findings that TTX abolished guanidine-induced potentials. Such an 
increased excitability in presynaptic structures of a neuronal circuit may 
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FIG. 6. A and B-effects ofguanidine on extraceilulariy recorded field potentials evoked by 
supramaximal stimulation of the lateral olfactory tract (50 V, 0.1 ms, 0.033 Hz). Each trace is 
the average of 10 responses: the calibration pulse was IO ms, 5 mV. The ieft panel in A shows 
the potential recorded after 13 min in 500 &CM guanidine superimposed over the control. Note 
the increase in amplitude and the marked late negative potential. These effects were reversed 
after 65 min of washing (right panel). The left panel in B shows the potential recorded after 10 
min in 2 mM guanidine superimposed over the control. After 28 min (right panel). the increase 
in amplitude produced by guanidine was reversed to a decrease; the amplitude of the late 
negative potential was also reduced. C-prolongation of the lateral olfactory tract compound 
action potential by 500 pM guanidine. The isolated tract was stimulated at 50 V, 0.1 ms. 0.33 
Hz and each trace is the average of loresponses; the calibration pulse was 1 ms, 1 mV. The left 
panel shows the response recorded after 30 min in guanidine superimposed over the control. 
The prolongation was an effect reversible after 60 min of washing (right panel). 
also explain the occurrence of afterdis~harges, which we observed during 
the action of higher concentrations of guanidine. 
The prolonged postsynaptic potentials recorded in&a- and extracellu- 
‘arly during exposure to guanidine, after a single orthodromic stimulus, are 
nost probably due to an increased amount of neurotransmitter released. 
rhis accords with observations made on neuromuscular junctions, where 
:uanidine was found to increase the quanta1 release of acetylcholine (10, 11, 
18,22,30). Although the mechanism of this effect is unknown as yet, it is 
)ossible that the increased duration of the LOT action potential, which we 
neasured, couid contribute to a facilitation of transmitter release in the 
olfactory cortex. Indeed, it has also been shown that guanidine increases 
ction potential duration in other excitable tissues such as mouse skeletal 
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muscle (IO) and lamprey spinal cord (18). However, intracellular 
recordings from pre- and postsynaptic sites in the chick ciliary ganglion 
indicated that the effect of guanidine on transmitter release was 
independent of alterations in the presynaptic spike (1). Furthermore, at 
neuromuscular junctions pretreated with TTX to block action potentials, 
transmitter release induced by electrotonic depolarization of nerve 
terminals was also facilitated by guanidine (16). 
Therefore it cannot be concluded that a prolongation of the presynaptic 
action potential is the only reason for the enhanced release of transmitter, 
and it may be possible that an increase in the amount of free Ca2+ in 
presynaptic nerve terminals may play an important role (16, 18). 
Another possible explanation for the prolongation of synaptic potentials 
is that guanidine may interact with postsynaptic receptors and/or ion 
channels. Such an interaction was proposed for pentobarbital, which also 
greatly prolongs synaptic potentials in the isolated olfactory cortex (28). As 
yet we cannot exclude this possibility, but it seems unlikely in view of the 
fact that at the neuromuscular junction, guanidine only increased 
stimulus-induced acetylcholine release and did not alter the response to 
acetylcholine iontophoretically applied to the muscle fiber (10,22). Further 
evidence against an interaction with postsynaptic receptors stems from our 
observation that guanidine hardly altered resting membrane potential and 
resistance, in agreement with observations on frog motoneurons (8), 
neuromuscular junctions (10, 18, 30), and chick ciliary ganglion (1). 
Our results indicate that guanidine probably enhances excitatory and 
inhibitory processes in an unspecific manner. Facilitation of excitatory 
transmission is suggested by the increased amplitude of the extracellularly 
recorded population EPSP in addition to intracellular recordings, which 
showed that, in guanidine, some neurons either fired more than one action 
potential in response to a single orthodromic stimulus or exhibited 
spontaneous afterdischarges. On the other hand, the marked prolongation 
of the IPSP (Fig. 1D) strongly suggests an increased release of inhibitory 
transmitter. 
Recently, the serum concentration of guanidine was measured in healthy 
humans after oral administration (19). From these data it was calculated 
that after 2 days of dosage [3 x 1 g/day; the maximum clinically used dose 
(17)], the serum concentration would be 400 to 650 PM (W. Mayer, personal 
communication). The fact that in our experiments concentrations of 
guanidine 3300 pM were effective in enhancing synaptic transmission, 
suggests that effects observed in the guinea pig isolated olfactory cortex 
may resemble those occurring in the human brain. If this is so, the following 
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points may help to explain the beneficial action of guanidine in human 
central nervous system diseases. (a) An increase in stimulus-induced 
transmitter release might help to overcome a reduction in the efficiency of 
synaptic transmission. (b) An enhancement of spontaneous transmitter 
release may exert a beneficia1 trophic action on postsynaptic receptors. (c) 
An increased excitability of single fibers as described for frog motor nerves 
and lamprey Muher axons (18) could improve conduction in degenerating 
nerve fibers. Finally, the paresthesia observed during guanidine treatment 
(17, 20) could be due to spontaneous potentials in cutaneous receptors as 
recorded in the toad (25). 
However, in view of the fact that at present nothing is known about 
changes in synaptic function or postsynaptic receptors in amyotrophic 
lateral sclerosis or spinal muscular atrophy, these ideas remain 
speculative. 
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